3,971
Views
28
CrossRef citations to date
0
Altmetric
Review

New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy

, , , , &
Pages 1967-1980 | Received 12 Sep 2017, Accepted 22 Oct 2017, Published online: 30 Oct 2017

Figures & data

Figure 1. NIRF imaging of liver-implanted CT26 colon tumours. (a) Whole body images of athymic nude mice bearing CT26 colon tumours in their liver tissues after intravenous injection of Cy5.5-P-HA-NPs as a function of time. Arrows indicate the sites of tumours. (b) Ex vivo fluorescence images of tumour-bearing livers and organs excised at 48 h post injection of NPs (5 mg/kg). (c) Representative histological images of normal liver and tumour slices stained with haematoxylin and eosin [Citation42]. Reprinted with permission from American Chemical Society (Copyright © 2011).

Figure 1. NIRF imaging of liver-implanted CT26 colon tumours. (a) Whole body images of athymic nude mice bearing CT26 colon tumours in their liver tissues after intravenous injection of Cy5.5-P-HA-NPs as a function of time. Arrows indicate the sites of tumours. (b) Ex vivo fluorescence images of tumour-bearing livers and organs excised at 48 h post injection of NPs (5 mg/kg). (c) Representative histological images of normal liver and tumour slices stained with haematoxylin and eosin [Citation42]. Reprinted with permission from American Chemical Society (Copyright © 2011).

Figure 2. In vivo tumour inhibition study. Balb/c nude mice were injected with PBS, free paclitaxel and HA-CA-Paclitaxel at Day 0 (n = 3). Comparison of tumour size on Day 8 of (A) Control (B) Paclitaxel (C) HA-CA-Paclitaxel (2 mg/kg) (D) HA-CA-Paclitaxel (5 mg/kg). Tumour inhibition data show mean tumour volume, of triplicate samples ± SD. *p < .05 relative to HA-CA-paclitaxel (2 mg/kg) and **p < .05 relative to control group [Citation70]. Reprinted with permission from Elsevier B.V. (Copyright © 2014) through Copyright Clearance Centre.

Figure 2. In vivo tumour inhibition study. Balb/c nude mice were injected with PBS, free paclitaxel and HA-CA-Paclitaxel at Day 0 (n = 3). Comparison of tumour size on Day 8 of (A) Control (B) Paclitaxel (C) HA-CA-Paclitaxel (2 mg/kg) (D) HA-CA-Paclitaxel (5 mg/kg). Tumour inhibition data show mean tumour volume, of triplicate samples ± SD. *p < .05 relative to HA-CA-paclitaxel (2 mg/kg) and **p < .05 relative to control group [Citation70]. Reprinted with permission from Elsevier B.V. (Copyright © 2014) through Copyright Clearance Centre.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.